A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification
Crossref DOI link: https://doi.org/10.1007/s00280-017-3447-x
Published Online: 2017-10-07
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moj, Daniel
Britz, Hannah
Burhenne, Jürgen
Stewart, Clinton F.
Egerer, Gerlinde
Haefeli, Walter E.
Lehr, Thorsten
License valid from 2017-10-07